WilliamWittmerMacLaughlinMD

Physician

Overview of Dr. MacLaughlin

Dr. William MacLaughlin, MD is an oncologist in Chesapeake, Virginia. He is currently licensed to practice medicine in Virginia, North Carolina, and Pennsylvania. He is affiliated with Chesapeake Regional Medical Center, Sentara Virginia Beach General Hospital, and Riverside Regional Medical Center.

Office
110 Wimbledon Sq
Suite E
Chesapeake, VA 23320
Book by Phone+1(757) 982-3164

Fax(757) 436-2912
Is this information wrong?

Education & Training

New York Presbyterian HospitalFellowship, Hematology and Medical Oncology, 1984 - 1987
Eastern Virginia Medical SchoolResidency, Internal Medicine, 1981 - 1984
New York Medical CollegeClass of 1981

Certifications & Licensure

NC State Medical License 1992 - 2022
PA State Medical License 1987 - 2002
VT State Medical License 1987 - 1990
NY State Medical License 1984 - 2023
VA State Medical License 1982 - 2022
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

5 citations
The effect in vitro of 2'-deoxycytidine on the metabolism and cytotoxicity of 2',3'-dideoxycytidine.
Kapil N. Bhalla, Li Gongrong, Steven Grant, John T. Cole, W. Maclaughlin, David J. Volsky> ;AIDS. 1990 May 1
Resolution of a photopenic lesion on bone imaging following chemotherapy for metastatic disease.
Joel M. Rosen, William W. MacLAUGHLIN, Robert M. Jaffe> ;Clinical Nuclear Medicine. 1987 Jul 1
9 citations
Cue elimination effects on discrimination behavior of rats with septal lesions.
Peter J. Donovick, Richard G. Burright, Roger D. Sikorszky, Nicholas J. Stamato, William W. Maclaughlin> ;Physiology & Behavior. 1978 Jan 1
6 citations
Phase I clinical and pharmacologic study of deoxycytidine.
Kapil N. Bhalla, M. Birkhofer, Simon Grant, M. A. Baker, W. Maclaughlin, John T. Cole, G. Graham> ;Leukemia. 1988 Oct 1
29 citations
Deoxycytidine preferentially protects normal versus leukemic myeloid progenitor cells from cytosine arabinoside-mediated cytotoxicity.
Kapil N. Bhalla, W. Maclaughlin, John T. Cole, Z. Arlin, M. A. Baker, G. Graham, Simon Grant> ;Blood. 1987 Aug 1
9 citations
Deoxycytidine stimulates the in vitro growth of normal CFU-GM and reverses the negative regulatory effects of acidic isoferritin and prostaglandin E1
Kapil N. Bhalla, John T. Cole, W. Maclaughlin, M. A. Baker, Z. Arlin, G. Graham, Steven Grant> ;Blood. 1986 Nov 1
5 citations
Effect of deoxycytidine on the metabolism and cytotoxicity of 5-aza-2'-deoxycytidine and arabinosyl 5-azacytosine in normal and leukemic human myeloid progenitor cells.
Kapil N. Bhalla, John T. Cole, W. Maclaughlin, Z. Arlin, M. A. Baker, G. Graham, Simon Grant> ;Leukemia. 1987 Dec 1
16 citations
2'-Deoxycytidine protects normal human bone marrow progenitor cells in vitro against the cytotoxicity of 3'-azido-3'-deoxythymidine with preservation of antiretroviral...
Kapil N. Bhalla, M. Birkhofer, Gen Li, Simon Grant, W. Maclaughlin, John T. Cole, G. Graham, David J. Volsky> ;Blood. 1989 Nov 1
Join now to see all

Hospital Affiliations

Riverside Regional Medical CenterNewport News, Virginia
Chesapeake Regional Medical CenterChesapeake, Virginia
Sentara Virginia Beach General HospitalVirginia Beach, Virginia

Insurance Accepted

Aetna Choice POS II
Anthem HealthKeepers HMO/POS
Anthem KeyCare PPO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Great West PPO
Humana ChoiceCare Network PPO
Kaiser Permanente
Multiplan PHCS PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment